Turnaround Tuesday: A Look at Emerging Markets

Mish Schneider | December 3, 2024

The DAX is a stock market index consisting of the 40 major German blue-chip companies trading on the Frankfurt Stock Exchange.  

Here are the top five weighted sectors: 

Sector Weightings 

Industrials 24.51% 

Financial Services 20.33% 

Technology 18.47% 

Consumer Cyclical 10.27% …


Technical Monday: Novo-Nordisk, A Love Story

Mish Schneider | December 2, 2024

Novo Nordisk, the company behind Ozempic and Wegovy, is now Europe's largest company as global demand for its drugs have soared.  

However, the Danish pharmaceutical began because of more personal reasons. 

In the early 1920s, Nobel laureate August Krogh and …


The Economic Modern Family Talks Turkey

Mish Schneider | November 27, 2024

While this is the last Daily of this week, I want to start with a quick rundown of the Economic Economic Modern Family. 

As Friday is a ½ day and Black Friday, we can only guess that based on a …


Turnaround Tuesday: Rivian

Mish Schneider | November 26, 2024

I have a few central themes for 2025. 

One is the ‘vanity’ trade based on the diet drugs. News today was that Biden administration is looking to expand coverage for the drugs through Medicare. 

That could be reversed by Trump …


Technical Monday: A Fresh Look at the “Vanity” Trade

Mish Schneider | November 25, 2024

With such a great start to the holiday week, we could not help but gloat a little about the stocks I have mentioned related to the diet drugs, or what I call the “vanity” trade.

IPAR (perfumes), ELF (cosmetics) ULTA …


Economic Modern Family-Granny Did It! Retail Rallies

Mish Schneider | November 24, 2024

How long have we talked about the massive nearly 11-month price consolidation in our dear Granny Retail XRT? 

What we waited for was a weekly close over 79.20, a level we have not seen since February 2022. 

The Family, catching …


Are Diet Drug Companies Over the Hump?

Mish Schneider | November 20, 2024

For hump Wednesday, I am asking the question on whether the two premier diet drug companies are finally over the hump and have stopped the bleed?

Today I read this:

WEIGHT-LOSS DRUG COVERAGE RISES AMONG LARGE US EMPLOYERS IN 2024: …


Has Granny Retail Reversed or Ever Breakout?

Mish Schneider | November 19, 2024

For Turnaround Tuesday, let’s reexamine the ETF XRT, which we have tracked all year. 

Since February 2024, XRT has been in a massive consolidation. 

While the ETF recently looked poised for a breakout and a weekly close over $80, the …


Technical Monday: How Key Ratios Measure Risk

Mish Schneider | November 18, 2024

I ended last week on Maggie Lake’s podcast.  

During the discussion, we covered a lot of topics, and I encourage you to go have a listen as we offer actionable information. 

One of the topics we covered is the notion …


Reality Sets into the Economic Modern Family

Mish Schneider | November 17, 2024

The week right after the election, the Family was downright jubilant.

This past week, the best word to describe them as is disappointed.

Disappointed is not as bad as say, dismayed.

Nonetheless, all the gains after the elections dissipated.

Some …